Literature DB >> 30561114

Effects of probiotic supplements on the progression of chronic kidney disease: A meta-analysis.

Sibei Tao1, Siying Tao2, Yiming Cheng1, Jing Liu1, Liang Ma1, Ping Fu1.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is a worldwide public health problem. Although accumulated data suggested that probiotic supplements played roles in CKD, the results remained controversial. Here, we performed a meta-analysis to assess the effects of probiotic supplements on the CKD progression.
METHODS: A systematic search was conducted through the PubMed, Embase and Cochrane databases until September 2018. Randomized controlled trials with control receiving placebo, evaluating the effects of probiotic supplements on CKD were included.
RESULTS: A total of 10 randomized controlled trials in 8 countries were selected. In the meta-analysis, urea level was significantly reduced in probiotics-administrated non-dialysis patients (mean differences (MD) = -30.01; 95% confidence interval (CI) = [-56.78, -3.25]; P = 0.03) while no significant change was found in the dialysis patients receiving probiotics (MD = 0.1; 95% CI = [-9.28, 9.48]; P = 0.98). Probiotic supplements also exhibited no effect on uric acid (MD = -0.43; 95% CI = [-1.19, 0.33]; P = 0.27), C-reactive protein (MD = -0.48; 95% CI = [-1.29, 0.33]; P = 0.24), creatinine (MD = -0.18; 95% CI = [-0.82, 0.47]; P = 0.59), and estimated glomerular filtration rate (MD = 2.10; 95% CI = [-1.31, 5.52]; P = 0.23) of CKD patients.
CONCLUSION: Our results highlighted that probiotic supplements exerted a statistically significant effect on urea levels in non-dialysis CKD population, while no evidence suggested that probiotics possessed meaningful impacts on the reduction of uric acid, C-reactive protein, creatinine and estimated glomerular filtration rate preservation of CKD population.
© 2018 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  chronic kidney disease; gut microbiota; meta-analysis; probiotic supplements; progression

Mesh:

Substances:

Year:  2019        PMID: 30561114     DOI: 10.1111/nep.13549

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  10 in total

Review 1.  The gut microbiota and its relationship with chronic kidney disease.

Authors:  Consuelo Plata; Cristino Cruz; Luz G Cervantes; Victoria Ramírez
Journal:  Int Urol Nephrol       Date:  2019-10-01       Impact factor: 2.370

Review 2.  Effect of probiotics on oxidative stress and inflammatory status in diabetic nephropathy: A systematic review and meta-analysis of clinical trials.

Authors:  Jalal Bohlouli; Iman Namjoo; Mohammad Borzoo-Isfahani; Mohammad Ali Hojjati Kermani; Zakiyeh Balouch Zehi; Amir Reza Moravejolahkami
Journal:  Heliyon       Date:  2021-01-10

Review 3.  Systematic Review of Nutrition Supplements in Chronic Kidney Diseases: A GRADE Approach.

Authors:  Pei-Chin Lin; Chu-Lin Chou; Shih-Hsiang Ou; Te-Chao Fang; Jin-Shuen Chen
Journal:  Nutrients       Date:  2021-01-30       Impact factor: 5.717

Review 4.  Probiotics, Prebiotics and Synbiotics-A Promising Strategy in Prevention and Treatment of Cardiovascular Diseases?

Authors:  Beata Olas
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

5.  Intestinal dysbiosis featuring abundance of Streptococcus associates with Henoch-Schönlein purpura nephritis (IgA vasculitis with nephritis) in adult.

Authors:  Jiaxing Tan; Zhengxia Zhong; Yi Tang; Wei Qin
Journal:  BMC Nephrol       Date:  2022-01-03       Impact factor: 2.388

6.  Uremia-Induced Gut Barrier Defect in 5/6 Nephrectomized Mice Is Worsened by Candida Administration through a Synergy of Uremic Toxin, Lipopolysaccharide, and (1➔3)-β-D-Glucan, but Is Attenuated by Lacticaseibacillus rhamnosus L34.

Authors:  Somkanya Tungsanga; Wimonrat Panpetch; Thansita Bhunyakarnjanarat; Kanyarat Udompornpitak; Pisut Katavetin; Wiwat Chancharoenthana; Piraya Chatthanathon; Naraporn Somboonna; Kriang Tungsanga; Somying Tumwasorn; Asada Leelahavanichkul
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 5.923

7.  Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort.

Authors:  Sandra Wagner; Thomas Merkling; Marie Metzger; Laetitia Koppe; Maurice Laville; Marie-Christine Boutron-Ruault; Luc Frimat; Christian Combe; Ziad A Massy; Bénédicte Stengel; Denis Fouque
Journal:  Front Nutr       Date:  2022-03-30

8.  Quality of Life and Social Support of People on Peritoneal Dialysis: Mixed Methods Research.

Authors:  Miquel Sitjar-Suñer; Rosa Suñer-Soler; Afra Masià-Plana; Emilia Chirveches-Pérez; Carme Bertran-Noguer; Concepció Fuentes-Pumarola
Journal:  Int J Environ Res Public Health       Date:  2020-06-14       Impact factor: 3.390

9.  The Administration of the Synbiotic Lactobacillus bulgaricus 6c3 Strain, Inulin and Fructooligosaccharide Decreases the Concentrations of Indoxyl Sulfate and Kidney Damage in a Rat Model.

Authors:  Alonso Jerez-Morales; José S Merino; Sindy T Díaz-Castillo; Carlos T Smith; Jorge Fuentealba; Humberto Bernasconi; Gerson Echeverría; Apolinaria García-Cancino
Journal:  Toxins (Basel)       Date:  2021-03-07       Impact factor: 4.546

10.  Cross-Talk between Probiotic Nissle 1917 and Human Colonic Epithelium Affects the Metabolite Composition and Demonstrates Host Antibacterial Effect.

Authors:  Karol Dokladny; John K Crane; Alex J Kassicieh; James B Kaper; Olga Kovbasnjuk
Journal:  Metabolites       Date:  2021-12-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.